Healthcare

Global Conjugate Vaccine Market Professional Survey Report 2017

  • QYR1554271
  • 102 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
This report studies Conjugate Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Bharat Biotech (India)

Biological E (India)

CSL Limited (Australia)

GlaxoSmithKline (U.K.)

Merck and Company (U.S.)

Neuron Biotech (U.S.)

Novartis AG (Switzerland)

Pfizer (U.S.)

Sanofi Pasteur (France)

By types, the market can be split into

Pneumococcal

Influenza

Diphtheria Tetanus Pertussis

Meningococcal

By Application, the market can be split into

Hospital

Medical Center

By Regions, this report covers (we can add the regions/countries as you want)

North America

China

Europe

Southeast Asia

Japan

India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Conjugate Vaccine Market Professional Survey Report 2017

1 Industry Overview of Conjugate Vaccine

1.1 Definition and Specifications of Conjugate Vaccine

1.1.1 Definition of Conjugate Vaccine

1.1.2 Specifications of Conjugate Vaccine

1.2 Classification of Conjugate Vaccine

1.2.1 Pneumococcal

1.2.2 Influenza

1.2.3 Diphtheria Tetanus Pertussis

1.2.4 Meningococcal

1.3 Applications of Conjugate Vaccine

1.3.1 Hospital

1.3.2 Medical Center

1.3.3 Application 3

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Conjugate Vaccine

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Conjugate Vaccine

2.3 Manufacturing Process Analysis of Conjugate Vaccine

2.4 Industry Chain Structure of Conjugate Vaccine

3 Technical Data and Manufacturing Plants Analysis of Conjugate Vaccine

3.1 Capacity and Commercial Production Date of Global Conjugate Vaccine Major Manufacturers in 2016

3.2 Manufacturing Plants Distribution of Global Conjugate Vaccine Major Manufacturers in 2016

3.3 R&D Status and Technology Source of Global Conjugate Vaccine Major Manufacturers in 2016

3.4 Raw Materials Sources Analysis of Global Conjugate Vaccine Major Manufacturers in 2016

4 Global Conjugate Vaccine Overall Market Overview

4.1 2012-2017E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2012-2017E Global Conjugate Vaccine Capacity and Growth Rate Analysis

4.2.2 2016 Conjugate Vaccine Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2012-2017E Global Conjugate Vaccine Sales and Growth Rate Analysis

4.3.2 2016 Conjugate Vaccine Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2012-2017E Global Conjugate Vaccine Sales Price

4.4.2 2016 Conjugate Vaccine Sales Price Analysis (Company Segment)

5 Conjugate Vaccine Regional Market Analysis

5.1 North America Conjugate Vaccine Market Analysis

5.1.1 North America Conjugate Vaccine Market Overview

5.1.2 North America 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2012-2017E Conjugate Vaccine Sales Price Analysis

5.1.4 North America 2016 Conjugate Vaccine Market Share Analysis

5.2 China Conjugate Vaccine Market Analysis

5.2.1 China Conjugate Vaccine Market Overview

5.2.2 China 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2012-2017E Conjugate Vaccine Sales Price Analysis

5.2.4 China 2016 Conjugate Vaccine Market Share Analysis

5.3 Europe Conjugate Vaccine Market Analysis

5.3.1 Europe Conjugate Vaccine Market Overview

5.3.2 Europe 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2012-2017E Conjugate Vaccine Sales Price Analysis

5.3.4 Europe 2016 Conjugate Vaccine Market Share Analysis

5.4 Southeast Asia Conjugate Vaccine Market Analysis

5.4.1 Southeast Asia Conjugate Vaccine Market Overview

5.4.2 Southeast Asia 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2012-2017E Conjugate Vaccine Sales Price Analysis

5.4.4 Southeast Asia 2016 Conjugate Vaccine Market Share Analysis

5.5 Japan Conjugate Vaccine Market Analysis

5.5.1 Japan Conjugate Vaccine Market Overview

5.5.2 Japan 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2012-2017E Conjugate Vaccine Sales Price Analysis

5.5.4 Japan 2016 Conjugate Vaccine Market Share Analysis

5.6 India Conjugate Vaccine Market Analysis

5.6.1 India Conjugate Vaccine Market Overview

5.6.2 India 2012-2017E Conjugate Vaccine Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2012-2017E Conjugate Vaccine Sales Price Analysis

5.6.4 India 2016 Conjugate Vaccine Market Share Analysis

6 Global 2012-2017E Conjugate Vaccine Segment Market Analysis (by Type)

6.1 Global 2012-2017E Conjugate Vaccine Sales by Type

6.2 Different Types of Conjugate Vaccine Product Interview Price Analysis

6.3 Different Types of Conjugate Vaccine Product Driving Factors Analysis

6.3.1 By Disease Indication of Conjugate Vaccine Growth Driving Factor Analysis

6.3.2 By Type of Conjugate Vaccine Growth Driving Factor Analysis

6.3.3 By Patient Stage of Conjugate Vaccine Growth Driving Factor Analysis

7 Global 2012-2017E Conjugate Vaccine Segment Market Analysis (by Application)

7.1 Global 2012-2017E Conjugate Vaccine Consumption by Application

7.2 Different Application of Conjugate Vaccine Product Interview Price Analysis

7.3 Different Application of Conjugate Vaccine Product Driving Factors Analysis

7.3.1 Hospital of Conjugate Vaccine Growth Driving Factor Analysis

7.3.2 Medical Center of Conjugate Vaccine Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Conjugate Vaccine

8.1 Bharat Biotech (India)

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Product A

8.1.2.2 Product B

8.1.3 Bharat Biotech (India) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Bharat Biotech (India) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.2 Biological E (India)

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Product A

8.2.2.2 Product B

8.2.3 Biological E (India) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Biological E (India) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.3 CSL Limited (Australia)

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Product A

8.3.2.2 Product B

8.3.3 CSL Limited (Australia) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 CSL Limited (Australia) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.4 GlaxoSmithKline (U.K.)

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Product A

8.4.2.2 Product B

8.4.3 GlaxoSmithKline (U.K.) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 GlaxoSmithKline (U.K.) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.5 Merck and Company (U.S.)

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Product A

8.5.2.2 Product B

8.5.3 Merck and Company (U.S.) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Merck and Company (U.S.) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.6 Neuron Biotech (U.S.)

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Product A

8.6.2.2 Product B

8.6.3 Neuron Biotech (U.S.) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Neuron Biotech (U.S.) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.7 Novartis AG (Switzerland)

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Product A

8.7.2.2 Product B

8.7.3 Novartis AG (Switzerland) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Novartis AG (Switzerland) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.8 Pfizer (U.S.)

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Product A

8.8.2.2 Product B

8.8.3 Pfizer (U.S.) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Pfizer (U.S.) 2016 Conjugate Vaccine Business Region Distribution Analysis

8.9 Sanofi Pasteur (France)

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Product A

8.9.2.2 Product B

8.9.3 Sanofi Pasteur (France) 2016 Conjugate Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Sanofi Pasteur (France) 2016 Conjugate Vaccine Business Region Distribution Analysis

9 Development Trend of Analysis of Conjugate Vaccine Market

9.1 Global Conjugate Vaccine Market Trend Analysis

9.1.1 Global 2017-2022 Conjugate Vaccine Market Size (Volume and Value) Forecast

9.1.2 Global 2017-2022 Conjugate Vaccine Sales Price Forecast

9.2 Conjugate Vaccine Regional Market Trend

9.2.1 North America 2017-2022 Conjugate Vaccine Consumption Forecast

9.2.2 China 2017-2022 Conjugate Vaccine Consumption Forecast

9.2.3 Europe 2017-2022 Conjugate Vaccine Consumption Forecast

9.2.4 Southeast Asia 2017-2022 Conjugate Vaccine Consumption Forecast

9.2.5 Japan 2017-2022 Conjugate Vaccine Consumption Forecast

9.2.6 India 2017-2022 Conjugate Vaccine Consumption Forecast

9.3 Conjugate Vaccine Market Trend (Product Type)

9.4 Conjugate Vaccine Market Trend (Application)

10 Conjugate Vaccine Marketing Type Analysis

10.1 Conjugate Vaccine Regional Marketing Type Analysis

10.2 Conjugate Vaccine International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Conjugate Vaccine by Region

10.4 Conjugate Vaccine Supply Chain Analysis

11 Consumers Analysis of Conjugate Vaccine

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Conjugate Vaccine Market Professional Survey Report 2017

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Conjugate Vaccine

Table Product Specifications of Conjugate Vaccine

Table Classification of Conjugate Vaccine

Figure Global Production Market Share of Conjugate Vaccine by Type in 2016

Figure Pneumococcal Picture

Table Major Manufacturers of Pneumococcal

Figure Influenza Picture

Table Major Manufacturers of Influenza

Figure Diphtheria Tetanus Pertussis Picture

Table Major Manufacturers of Diphtheria Tetanus Pertussis

Figure Meningococcal Picture

Table Major Manufacturers of Meningococcal

Table Applications of Conjugate Vaccine

Figure Global Consumption Volume Market Share of Conjugate Vaccine by Application in 2016

Figure Hospital Examples

Table Major Consumers in Hospital

Figure Medical Center Examples

Table Major Consumers in Medical Center

Figure Market Share of Conjugate Vaccine by Regions

Figure North America Conjugate Vaccine Market Size (Million USD) (2012-2022)

Figure China Conjugate Vaccine Market Size (Million USD) (2012-2022)

Figure Europe Conjugate Vaccine Market Size (Million USD) (2012-2022)

Figure Southeast Asia Conjugate Vaccine Market Size (Million USD) (2012-2022)

Figure Japan Conjugate Vaccine Market Size (Million USD) (2012-2022)

Figure India Conjugate Vaccine Market Size (Million USD) (2012-2022)

Table Conjugate Vaccine Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Conjugate Vaccine in 2016

Figure Manufacturing Process Analysis of Conjugate Vaccine

Figure Industry Chain Structure of Conjugate Vaccine

Table Capacity and Commercial Production Date of Global Conjugate Vaccine Major Manufacturers in 2016

Table Manufacturing Plants Distribution of Global Conjugate Vaccine Major Manufacturers in 2016

Table R&D Status and Technology Source of Global Conjugate Vaccine Major Manufacturers in 2016

Table Raw Materials Sources Analysis of Global Conjugate Vaccine Major Manufacturers in 2016

Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Conjugate Vaccine 2012-2017

Figure Global 2012-2017E Conjugate Vaccine Market Size (Volume) and Growth Rate

Figure Global 2012-2017E Conjugate Vaccine Market Size (Value) and Growth Rate

Table 2012-2017E Global Conjugate Vaccine Capacity and Growth Rate

Table 2016 Global Conjugate Vaccine Capacity (K Units) List (Company Segment)

Table 2012-2017E Global Conjugate Vaccine Sales (K Units) and Growth Rate

Table 2016 Global Conjugate Vaccine Sales (K Units) List (Company Segment)

Table 2012-2017E Global Conjugate Vaccine Sales Price (USD/Unit)

Table 2016 Global Conjugate Vaccine Sales Price (USD/Unit) List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure North America 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure North America 2016 Conjugate Vaccine Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure China 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure China 2016 Conjugate Vaccine Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure Europe 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure Europe 2016 Conjugate Vaccine Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure Southeast Asia 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure Southeast Asia 2016 Conjugate Vaccine Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure Japan 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure Japan 2016 Conjugate Vaccine Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption (K Units) of Conjugate Vaccine 2012-2017E

Figure India 2012-2017E Conjugate Vaccine Sales Price (USD/Unit)

Figure India 2016 Conjugate Vaccine Sales Market Share

Table Global 2012-2017E Conjugate Vaccine Sales (K Units) by Type

Table Different Types Conjugate Vaccine Product Interview Price

Table Global 2012-2017E Conjugate Vaccine Sales (K Units) by Application

Table Different Application Conjugate Vaccine Product Interview Price

Table Bharat Biotech (India) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Bharat Biotech (India) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Bharat Biotech (India) Conjugate Vaccine Business Region Distribution

Table Biological E (India) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Biological E (India) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Biological E (India) Conjugate Vaccine Business Region Distribution

Table CSL Limited (Australia) Information List

Table Product A Overview

Table Product B Overview

Table 2015 CSL Limited (Australia) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 CSL Limited (Australia) Conjugate Vaccine Business Region Distribution

Table GlaxoSmithKline (U.K.) Information List

Table Product A Overview

Table Product B Overview

Table 2016 GlaxoSmithKline (U.K.) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 GlaxoSmithKline (U.K.) Conjugate Vaccine Business Region Distribution

Table Merck and Company (U.S.) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Merck and Company (U.S.) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Merck and Company (U.S.) Conjugate Vaccine Business Region Distribution

Table Neuron Biotech (U.S.) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Neuron Biotech (U.S.) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Neuron Biotech (U.S.) Conjugate Vaccine Business Region Distribution

Table Novartis AG (Switzerland) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Novartis AG (Switzerland) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Novartis AG (Switzerland) Conjugate Vaccine Business Region Distribution

Table Pfizer (U.S.) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Pfizer (U.S.) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Pfizer (U.S.) Conjugate Vaccine Business Region Distribution

Table Sanofi Pasteur (France) Information List

Table Product A Overview

Table Product B Overview

Table 2016 Sanofi Pasteur (France) Conjugate Vaccine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2016 Sanofi Pasteur (France) Conjugate Vaccine Business Region Distribution

Figure Global 2017-2022 Conjugate Vaccine Market Size (K Units) and Growth Rate Forecast

Figure Global 2017-2022 Conjugate Vaccine Market Size (Million USD) and Growth Rate Forecast

Figure Global 2017-2022 Conjugate Vaccine Sales Price (USD/Unit) Forecast

Figure North America 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Figure China 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Figure Europe 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Figure Southeast Asia 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Figure Japan 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Figure India 2017-2022 Conjugate Vaccine Consumption Volume (K Units) and Growth Rate Forecast

Table Global Sales Volume (K Units) of Conjugate Vaccine by Type 2017-2022

Table Global Consumption Volume (K Units) of Conjugate Vaccine by Application 2017-2022

Table Traders or Distributors with Contact Information of Conjugate Vaccine by Region

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370